# Mirtazapine and Methamphetamine Drug-drug Interaction Study

> **NCT04614584** · PHASE1 · COMPLETED · sponsor: **San Francisco Department of Public Health** · enrollment: 15 (actual)

## Conditions studied

- Methamphetamine Use Disorder
- Drug Interaction
- Cardiovascular Abnormalities

## Interventions

- **DRUG:** Mirtazapine
- **DRUG:** Methamphetamine

## Key facts

- **NCT ID:** NCT04614584
- **Lead sponsor:** San Francisco Department of Public Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-03
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04614584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04614584, "Mirtazapine and Methamphetamine Drug-drug Interaction Study". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04614584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*